In the recent past, a distinct role for cholesterol in promoting ER+ BC progression has emerged in preclinical studies, unraveling the promising connections between 27HC, CYP27A1, and ER+ breast cancer progression. The gene discussed is CYP27A1; the disease is breast cancer.